Company flagged

Hitachi America, Ltd., Particle Therapy Division

Company reviews

Type Company Card addedAugust 10 Threat lists flagged Reviews1
people’s rating
—
nobody has rated it yet. Yours will be the first.
5 0 4 0 3 0 2 0 1 0
Astrina AI 4.0

Counted separately and kept out of the people’s average — otherwise one machine score would read as the readers’ opinion.

Threat lists · flagged Product safety recall

Official safety regulators published alerts about a product of this kind.

The record is filed under the name, not under a barcode or a company number: it describes things of this kind, not necessarily the one in front of you.

Alerts on record3 HazardDuring positioning within the system's 3D to 3D matching mode while transferring CBCT images, when the Float Image Selection button is pressed, it may display CBCT images that are insufficie First alertMay 27, 2024 Latest alertMay 27, 2024 On our lists sinceAugust 10, 2026

What to do: Check the maker, the batch and the date of the exact item you have — the alert is about this kind of product.

Where this came from: openFDA device recalls — An official government safety register — product recalls and safety alerts.

Is this your listing? Sign in to claim it and reply to reviews.

Astrina Astrina AI Astrina AI rating 2026-09-18
Hitachi America, Ltd., Particle Therapy Division belongs to the heavy end of cancer treatment, where the equipment is massive and the buying decision sits with hospitals and oncology centers. By our assessment, the real strength is the physical precision of particle therapy systems, which are built for very targeted radiation treatment rather than broad, one-size-fits-all machines. The trade-off is scale: this is expensive, infrastructure-heavy medicine that asks for specialized rooms, specialized staff, and long planning. In practice it is the opposite of a casual clinical device; it is a whole treatment platform that changes how a center thinks about radiotherapy. That puts it well above ordinary radiation gear and into a small, technical corner of the field where only some facilities can participate. People who need advanced oncology infrastructure will see the point immediately, while general buyers will not have any use for it. The ceiling is the obvious one: when a system is this specialized, it can be impressive without ever being widespread.
Report

What is wrong with this review? A moderator reads every report.

We do not tell the author who reported them.
No live reviews here yet The first review from an account gets the green tick and sets the average for this listing. Write the first one
Have more to say? A full review with photos, video and YouTube clips — a separate page of your own. Write a full review
Write a review

Optional. With it your review counts towards that exact location, not the chain as a whole.

Guest reviews are published after moderation. Sign in to publish instantly.

What this page answers